SANUWAVE Health to Participate in 37th Annual Roth Conference

Rhea-AI Summary

SANUWAVE Health (OTCQB: SNWV) announced its participation in the 37th Annual Roth Conference, scheduled for March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California. CEO Morgan Frank will be available for one-on-one meetings with investors throughout the conference.

The Annual Roth Conference is one of the nation's largest small-cap company events, featuring approximately 500 private and public companies from various growth sectors. The conference format includes company presentations, Q&A sessions, and management meetings, covering sectors such as consumer, healthcare, industrial growth, sustainability, and technology.

SANUWAVE Health specializes in non-invasive medical systems for skin, musculoskeletal tissue, and vascular structure regeneration. The company's wound care portfolio utilizes patented energy transfer technologies to support natural healing processes across wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular applications.

EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank, Chief Executive Officer, will participate in the 37^th Annual Roth Conference to be held on March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California.

Management will be available for one-on-one meetings throughout the conference. Interested investors should contact their Roth representative or email snwv@fnkir.com to schedule a meeting.

About the Roth Conference

The Annual ROTH Conference is one of the largest in the nation for small-cap companies, combining company presentations, Q&A sessions and management 1-on-1 meetings. The format provides investors the opportunity to hear from and meet with executive management from approximately 500 private and public companies in a variety of growth sectors. Roth’s award-winning Research Team identifies distinguished presenting companies across broad sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology and more.

About SANUWAVE

SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.

SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.

Contact: investors@sanuwave.com

FAQ

When and where is SANUWAVE Health (SNWV) presenting at the 2025 Roth Conference?

SANUWAVE Health will participate in the 37th Annual Roth Conference from March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California.

How can investors schedule meetings with SANUWAVE Health (SNWV) at the 2025 Roth Conference?

Investors can schedule meetings by contacting their Roth representative or emailing snwv@fnkir.com.

What are SANUWAVE Health's (SNWV) main product areas and technologies?

SANUWAVE Health focuses on non-invasive medical systems using patented energy transfer technologies for wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular applications.

What is the scope of the 2025 Roth Conference where SNWV is participating?

The Roth Conference is one of the largest small-cap company events in the nation, featuring approximately 500 private and public companies across various growth sectors including healthcare, technology, and sustainability.